Danish pharmaceutical giant Novo Nordisk is well on the way to achieving its 2025 goal for sales of weight loss drugs three years early. There is therefore a good chance that a new target will be revealed at the company’s upcoming capital markets day, on March 3.
”The goal will be within touching distance well before the 2025 deadline,” says CEO Lars Fruergaard Jørgensen to MarketWire, adding:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Consultant Manager 
IRT Manager, Clinical Drug Supply 
Project Manager & Scrum Master 
Account Manager 
Cell Culture Scientist/Senior Scientist 
Quality System Manager 
Clinical Trial Manager 
Director for innovative pre-clinical testing unit 
Senior IT Network Engineer 
Senior Project Manager (GMP - Life Science) 
Senior Chemical Safety Advisor 
Client Talent Acquisition Specialist 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Director Global Engineering 
Nordic Medical Affairs Manager 
Strategic Procurement Manager, Direct Spend (Category Manager)